LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-Edge Technology Arsenal Biosciences, Inc. is leveraging CRISPR-enabled genome editing and logic gate technology for precise tumor targeting. This innovative approach presents a unique selling point for oncology-related partnerships and collaborations.

Strategic Partnerships The recent partnership with Thermo Fisher showcases Arsenal Biosciences, Inc.'s commitment to advancing cell therapy manufacturing. This collaboration can be leveraged to explore joint sales opportunities and expand market reach.

Financial Stability With significant funding of $85 million and revenue in the range of $10-50 million, Arsenal Biosciences, Inc. demonstrates financial stability. This stability makes them an attractive prospect for large-scale purchases or investments.

Specialized Product Line Focused on developing multi-functional CAR-T cell therapies for solid tumors, Arsenal Biosciences, Inc. has a unique product line tailored to address critical unmet needs in the oncology space. This specialization can be highlighted for targeted sales to oncology centers.

Upcoming Leadership Addition The upcoming appointment of Nate Hardy as Chief Financial Officer presents an opportunity for networking and building new relationships within Arsenal Biosciences, Inc. This transition can be utilized to explore potential business collaborations or sales strategies aligned with the new leadership direction.

Similar companies to Arsenal Biosciences, Inc.

Arsenal Biosciences, Inc. Tech Stack

Arsenal Biosciences, Inc. uses 8 technology products and services including Ansible, git, Shopify, and more. Explore Arsenal Biosciences, Inc.'s tech stack below.

  • Ansible
    Configuration Management
  • git
    Development
  • Shopify
    E-commerce
  • Microsoft
    Miscellaneous
  • Gatsby
    Page Builders
  • Microsoft Azure
    Platform As A Service
  • Yoast SEO
    Search Engines
  • WPMU DEV Smush
    Web Platform Extensions

Media & News

Arsenal Biosciences, Inc.'s Email Address Formats

Arsenal Biosciences, Inc. uses at least 1 format(s):
Arsenal Biosciences, Inc. Email FormatsExamplePercentage
FLast@arsenalbio.comJDoe@arsenalbio.com
89%
Last@arsenalbio.comDoe@arsenalbio.com
6%
First@arsenalbio.comJohn@arsenalbio.com
4%
FL@arsenalbio.comJD@arsenalbio.com
1%

Frequently Asked Questions

Where is Arsenal Biosciences, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s main headquarters is located at South San Francisco , CA 94080 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Arsenal Biosciences, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s official website is arsenalbio.com and has social profiles on LinkedIn.

How much revenue does Arsenal Biosciences, Inc. generate?

Minus sign iconPlus sign icon
As of September 2024, Arsenal Biosciences, Inc.'s annual revenue reached $35M.

What is Arsenal Biosciences, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Arsenal Biosciences, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2024, Arsenal Biosciences, Inc. has approximately 268 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer: N. H.Chief People Officer: B. N.Chief Scientific Officer: N. H.. Explore Arsenal Biosciences, Inc.'s employee directory with LeadIQ.

What industry does Arsenal Biosciences, Inc. belong to?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc. operates in the Biotechnology Research industry.

What technology does Arsenal Biosciences, Inc. use?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s tech stack includes AnsiblegitShopifyMicrosoftGatsbyMicrosoft AzureYoast SEOWPMU DEV Smush.

What is Arsenal Biosciences, Inc.'s email format?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s email format typically follows the pattern of . Find more Arsenal Biosciences, Inc. email formats with LeadIQ.

How much funding has Arsenal Biosciences, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2024, Arsenal Biosciences, Inc. has raised $85M in funding. The last funding round occurred on Oct 17, 2019 for $85M.

When was Arsenal Biosciences, Inc. founded?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc. was founded in 2019.
Arsenal Biosciences, Inc.

Arsenal Biosciences, Inc.

Biotechnology ResearchCalifornia, United States201-500 Employees

ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise CRISPR-enabled genome editing, integrated circuits incorporating logic gates for improved tumor targeting, and therapeutic enhancements enabling multiple pharmaceutical functions. With our programmable and computationally driven approach, we aim for enhanced and broader efficacy, increased patient safety, reduced provider costs and expanded market access. Our team is engineering living medicines to attack cancer’s inherent multi-faceted nature and bring dramatic improvements to the lives of patients. 

Section iconCompany Overview

Headquarters
South San Francisco , CA 94080 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
201-500

Section iconFunding & Financials

  • $85M

    Arsenal Biosciences, Inc. has raised a total of $85M of funding over 1 rounds. Their latest funding round was raised on Oct 17, 2019 in the amount of $85Mas a Series A.

  • $10M$50M

    Arsenal Biosciences, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $85M

    Arsenal Biosciences, Inc. has raised a total of $85M of funding over 1 rounds. Their latest funding round was raised on Oct 17, 2019 in the amount of $85Mas a Series A.

  • $10M$50M

    Arsenal Biosciences, Inc.'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.